Aligos Therapeutics

This early-stage study tested a new oral medication called ALG-000184 for people with chronic hepatitis B. The main goals were to see if the drug is safe, how the body handles it, and if it can lower the amount of hepatitis B virus in the blood. The study involved healthy volunte…

This study tested a potential oral medicine for COVID-19, called ALG-097558, to see how it is processed in the body of people with moderate liver problems compared to healthy people. Sixteen participants took the drug twice a day. The main goal was to measure the drug's levels in…

This early study tested an oral COVID-19 drug called ALG-097558. It aimed to see how the drug is processed in the body of people with severe kidney problems compared to healthy people. The main goal was to check if the drug is safe and how kidney function changes the amount of dr…